ArticleBMJ open2023

Neoadjuvant chemoradiation therapy combined with immunotherapy for microsatellite stable ultra-low rectal cancer (CHOICE II): study protocol of a multicentre prospective randomised clinical trial.

Leqi Zhou et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.